|
Volumn 12, Issue 23, 2013, Pages 3579-3580
|
mTOR/PRAS40 interaction: Hypertrophy or proliferation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUCOSE;
GROWTH FACTOR;
INSULIN;
MAMMALIAN TARGET OF RAPAMYCIN;
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1;
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2;
MUTANT PROTEIN;
PROLINE;
PROLINE RICH AKT SUBSTRATE 40;
PROTEIN KINASE B;
RAPAMYCIN;
REGULATOR PROTEIN;
UNCLASSIFIED DRUG;
CANCER GROWTH;
CELL CYCLE;
CELL CYCLE ARREST;
CELL CYCLE REGULATION;
CELL GROWTH;
CELL PROLIFERATION;
CELL SIZE;
CELL SURVIVAL;
CYTOSOL;
DROSOPHILA;
EDITORIAL;
GENE THERAPY;
HEART DISEASE;
HEART FAILURE;
HEART FUNCTION;
HEART VENTRICLE HYPERTROPHY;
HEART VENTRICLE REMODELING;
HOMEOSTASIS;
HUMAN;
HYPERTENSION;
HYPERTROPHY;
LETHALITY;
MELANOMA CELL;
METABOLISM;
NEOPLASM;
NONHUMAN;
PROTEIN BINDING;
PROTEIN PHOSPHORYLATION;
PROTEIN PROTEIN INTERACTION;
SIGNAL TRANSDUCTION;
CARDIAC;
CELL CYCLE;
GROWTH;
HYPERTROPHY;
MTOR;
MTORC1;
PRAS40;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
CELL PROLIFERATION;
HUMANS;
HYPERTROPHY;
PHOSPHORYLATION;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
TOR SERINE-THREONINE KINASES;
|
EID: 84890275408
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.26822 Document Type: Editorial |
Times cited : (15)
|
References (8)
|